The Medicaid Services Investment & Accountability Act, House Resolution 1839, became law on April 18, 2019. The bill alters several Medicaid programs and funding provisions. In a key provision, it establishes a new health home option for medically complex children. It temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services. The bill also requires that drug manufacturers with Medicaid rebate agreements for covered outpatient drugs disclose drug product information. If they have knowingly misclassifying drugs so as to reduce the amount of the rebates paid to states, the . . .